Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation

Multiple Sclerosis

Volumn 5, Issue 1, 1999, Pages 17-21

  Karussis, Dimitrios ^a   Vourka Karussis, Urania ^a   Mizrachi Koll, Rachel ^a   Abramsky, Oded ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

BMT; EAE; Multiple sclerosia cyclophosphamide; Tolerance

Indexed keywords

CYCLOPHOSPHAMIDE; FREUND ADJUVANT; MYELIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; BORDETELLA; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PROVOCATION TEST; RELAPSE;

ANIMALS; ANTIBODY FORMATION; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED STRAINS; TIME FACTORS; TRANSPLANTATION, ISOGENEIC;

EID: 0033042841     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245899701564272     Document Type: Article

References (38)

1. Raine C. (1984) Biology of disease. Analysis of autoimmune demyelination; Its impact upon Multiple Sclerosis. Labor Invest 50: 608-635.
2. Hafler DA, Weiner HL. (1989) MS: a CNS and systemic autoimmune disease. Immunol Today 10: 104-107.
3. Bernard CCA, Carnegie PR. (1975) Experimental autoimmune encephalomyelitis in mice: immunological response to mouse spinal cord and myelin basic protein. J Immunol 114: 1537-1540.
4. Paterson PY. (1976) Experimental allergic encephalomyelitis induction, pathogenesis and suppression. In: Textbook of Immunopathology (eds Miescher PA, Mueller-Eberhard J), p 179. New York, Grune and Straton.
5. Raine CS, Barnett LB, Brown A, Behar T, MFarlin DE. (1980) Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab Invest 43: 150-157.
6. MacPhee IA, Mason DW. (1990) Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease. J Neuroimmunol. 27: 9-19.
7. Willenborg DO. (1979) Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinoculation. J Immunol 123: 1145-1150.
8. Ben-Nun A, Ron Y, Cohen IR. (1980) Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy, and ageing. Nature 288: 389-390.
9. Morton JI, Benjamin VS. (1979) Transplantation of autoimmune potential. Reversal of the NZB autoimmune syndrome by bone marrow transplantation. Transplantation 27: 133-134.
10. Ikehara S et al. (1985) Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc Natl Acad Sci 82: 7743-7747.
11. Himeno K, Good R. (1988) Marrow transplantation from tolerant donors to treat and prevent autoimmune disease in BXSB mice. Proc Natl Acad Sci 85: 2235-2239.
12. Theophilopoulos A. (1982) Role of the thymus in murine lupus and cellular transfer of the disease. Arthritis Rheumat 25: 726-733.
13. van Gelder M, Mulder AH, van Bekkum DW. (1996) Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation. Transplantation 62: 810-818.
14. van Gelder M, van Bekkum DW. (1995) Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant 16: 343-351.
15. Karussis DM et al. (1992) Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance with high dose cyclophosphamide followed by syngeneic bone marrow transplantation. J Neuroimmunol 39: 201-210.
16. Karussis DM et al. (1992) Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol 148: 1693-1698.
17. Karussis DM et al. (1993) Prevention and reversal of adoptively transferred chronic-relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplanation. J Clin Invest 92: 765-772.
18. Karussis DM et al. (1995) Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT). Clin Exp Immunol 100: 111-117.
19. van Gelder M, van Bekkum DW. (1996) Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplant 18: 1029-1034.
20. Van Gelder M, Kinwel-Bohre EP, Van Bekkum DW. (1993) Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 11: 233-241.
21. Diebler GE, Martenson RE, Kies MW. (1972) Large scale preparation of MBP from central nervous tissue of several mammalian species. Prep Biochem 2: 139-165.
22. Ben-Nun A, Lando Z. (1983) Detection of autoimmune cells proliferating to myelin basic protein and selection of T-cell lines that mediate experimental allergic encephalomyelitis (EAE) in mice. J Immunol 130: 1205-1209.
23. Goodkin DE at al. (1995) Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis [see comments]. Ann Neurol 37: 30-40.
24. Ellison GW et al. (1988) Clinical experience with azathioprine: the pros. Neurology 38: 20-23.
25. Rudge P. (1988) Cyclosporine and multiple sclerosis: the cons. Neurology 38: 29-30.
26. Lisak RP. (1988) Overview of the rationale for immunomodulating therapies in multiple sclerosis. Neurology 38: 5-8.
27. The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. (1991) The Canadian Cooperative Multiple Sclerosis Study Group [see comments]. Lancet 337: 441-446.
28. Cook SD et al. (1986) Effect of total lymphoid irradiation in chronic progressive multiple sclerosis. Lancet 1: 1405-1409.
29. Staykova M, Goranov I, Nikolov T. (1978) L'influence Du cyclophosphamide sur le development de EAE. Ann Immunol 129: 415-427.
30. Rosenthale ME, Datko KJ, Kassarich L, Shneider F. (1969) Chemotherapy of experimental allergic encephalomyelitis (EAE). Arch Int Pharmacodyn 179: 251-275.
31. Levine S, Sowinski R. (1977) Suppression of the hyperacute form of EAE by drugs. Arch Int Pharmacodyn 230: 309-318.
32. Slavin S et al. (1993) Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders. Transplant Proc 25: 1274-1275.
33. Wood KJ. (1996) New concepts in tolerance. Clin Transplant 10: 93-99.
34. Burt RK, Burns W, Hess A. (1995) Bone marrow transplantation for multiple sclerosis [editorial]. Bone Marrow Transplant 16: 1-6.
35. Kazis A et al. (1996) Autologous blood stem cell transplantation in the treatment of multiple sclerosis. Eur J Neurol 3: 54.
36. McAllister LD, Beatty PG, Rose J. (1997) Allogeneic bone marrow transplant for chronic myelogonous leukemia in a patient with multiple sclerosis. Bone Marrow Transplant 19: 395-397.
37. Marmont AM. (1993) Immune ablation with stem-cell rescue: a possible cure for systemic lupus erythematosus? Lupus 2: 151-156.
38. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC. (1993) Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 20: 137-140.